ViBA

Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models.

Arevalo HJ, Vadakkumpadan F, Guallar E · Nature communications · 2016 · Article

10.1038/ncomms11437

Verified evidence

Personalized model risk assessment

adec2288-e6b0-58d3-b7e2-38dc72f749e5
Clinical events and scalesRisk and probability estimates

Prediction source Version of record · PDF page(s) 5

Study 2fb72a37-7524-5dc6-a3dd-c6e7f987f374 · Prediction record (JSON)

Prediction fields

Comparator
experimental_or_observational_reference · PDF page(s) 5
Endpoint
post_infarction_arrhythmia_primary_endpoint__hazard_ratio · PDF page(s) 5
Family
clinical_outcomes · PDF page(s) 5
Measured variable
post_infarction_arrhythmia_primary_endpoint · PDF page(s) 5
Measurement role
clinical_outcome · PDF page(s) 5
Metric
hazard_ratio · PDF page(s) 5
Reference type
observed_clinical_reference · PDF page(s) 5
Reported time window
mean clinical follow-up of 4.8 ± 2.9 years for the signed composite ventricular-arrhythmia endpoint · PDF page(s) 2
Role
clinical_outcome · PDF page(s) 5
Scenario
retrospective_blinded_outcome_assessment · PDF page(s) 5

Validation Direct comparison · Same source · Sample overlap · Supports · Matched conditions · Statistically significant